TNFSF10 and cholangiocarcinoma: Mcl-1 inhibition of the mitochondrial pathway of cell death is especially relevant to cholangiocarcinoma cells as they paradoxically express TRAIL in vivo, and likely must continuously circumvent TRAIL cytotoxic signaling for survival [16].